Cai Jianwen, Li Peiyi, Li Weimin, Hao Xuechao, Li Sheyu, Zhu Tao
Department of Anesthesiology, West China Hospital of Sichuan University, No. 17 Section 3 Renmin South Road, Chengdu, 610000, China, 86 18681357952.
Laboratory of Anesthesia and Critical Care Medicine, West China Hospital of Sichuan University, Chengdu, China.
JMIR Diabetes. 2025 Apr 8;10:e70475. doi: 10.2196/70475.
Type 2 diabetes mellitus affects over 500 million people globally, with 10%-20% requiring surgery. Patients with diabetes are at increased risk for perioperative complications, including prolonged hospital stays and higher mortality, primarily due to perioperative hyperglycemia. Managing blood glucose during the perioperative period is challenging, and conventional monitoring is often inadequate to detect rapid fluctuations. Clinical decision support systems (CDSS) are emerging tools to improve perioperative diabetes management by providing real-time glucose data and medication recommendations. This viewpoint examines the role of CDSS in perioperative diabetes care, highlighting their benefits and limitations. CDSS can help manage blood glucose more effectively, preventing both hyperglycemia and hypoglycemia. However, technical and integration challenges, along with clinician acceptance, remain significant barriers.
全球有超过5亿人患有2型糖尿病，其中10%-20%的患者需要进行手术。糖尿病患者围手术期并发症的风险增加，包括住院时间延长和死亡率升高，主要原因是围手术期高血糖。围手术期血糖管理具有挑战性，传统监测往往不足以检测快速波动。临床决策支持系统（CDSS）是一种新兴工具，通过提供实时血糖数据和用药建议来改善围手术期糖尿病管理。本文观点探讨了CDSS在围手术期糖尿病护理中的作用，强调了其益处和局限性。CDSS有助于更有效地管理血糖，预防高血糖和低血糖。然而，技术和整合挑战以及临床医生的接受度仍然是重大障碍。
